Diffusion kurtosis and quantitative susceptibility mapping MRI are sensitive to structural abnormalities in amyotrophic lateral sclerosis

Objective: To construct a clinical diagnostic biomarker using state-of-the-art microstructural MRI in the motor cortex of people with amyotrophic lateral sclerosis (ALS). Methods: Clinical and MRI data were obtained from 21 ALS patients (aged 54 ± 14 years, 33% female) and 63 age- and gender-matched...

Full description

Bibliographic Details
Main Authors: Thomas Welton, Jerome J. Maller, R. Marc Lebel, Ek T. Tan, Dominic B. Rowe, Stuart M. Grieve
Format: Article
Language:English
Published: Elsevier 2019-01-01
Series:NeuroImage: Clinical
Online Access:http://www.sciencedirect.com/science/article/pii/S2213158219303031
id doaj-90bcab37d5cc45a888f6997b29127c51
record_format Article
spelling doaj-90bcab37d5cc45a888f6997b29127c512020-11-25T01:52:35ZengElsevierNeuroImage: Clinical2213-15822019-01-0124Diffusion kurtosis and quantitative susceptibility mapping MRI are sensitive to structural abnormalities in amyotrophic lateral sclerosisThomas Welton0Jerome J. Maller1R. Marc Lebel2Ek T. Tan3Dominic B. Rowe4Stuart M. Grieve5Sydney Translational Imaging Laboratory, Heart Research Institute, Charles Perkins Centre, University of Sydney, AustraliaSydney Translational Imaging Laboratory, Heart Research Institute, Charles Perkins Centre, University of Sydney, Australia; GE Healthcare, Richmond, Victoria, AustraliaGE Healthcare, Calgary, Alberta, CanadaGE Global Research, Niskayuna, NY, USAMND Research Centre, Faculty of Medicine and Health Sciences, Macquarie University, NSW, Australia; Macquarie University Hospital, Macquarie, AustraliaSydney Translational Imaging Laboratory, Heart Research Institute, Charles Perkins Centre, University of Sydney, Australia; Macquarie University Hospital, Macquarie, Australia; Department of Radiology, Royal Prince Alfred Hospital, Sydney, Australia; Corresponding author at: Sydney Translational Imaging Laboratory, Heart Research Institute, D17 Charles Perkins Centre and Sydney Medical School, The University of Sydney, NSW 2006, Australia.Objective: To construct a clinical diagnostic biomarker using state-of-the-art microstructural MRI in the motor cortex of people with amyotrophic lateral sclerosis (ALS). Methods: Clinical and MRI data were obtained from 21 ALS patients (aged 54 ± 14 years, 33% female) and 63 age- and gender-matched controls (aged 48 ± 18 years, 43% female). MRI was acquired at 3T and included T1-weighted scan (for volumetrics), arterial spin labelling (for cerebral blood flow), susceptibility-weighted angiography (for iron deposition) and multiband diffusion kurtosis imaging (for tissue microstructure). Group differences in imaging measures in the motor cortex were tested by general linear model and relationships to clinical variables by linear regression. Results: The ALS group had mild-to-moderate impairment (disease duration: 1.8 ± 0.8 years; ALS functional rating scale 40.2 ± 6.0; forced vital capacity 83% ± 22%). No age or gender differences were present between groups. We found significant group differences in diffusion kurtosis metrics (apparent, mean, radial and axial kurtosis: p < .01) and iron deposition in the motor cortex (p = .03). Within the ALS group, we found significant relationships between motor cortex volume, apparent diffusion and disease duration (adjusted R2 = 0.27, p = .011); and between the apparent and radial kurtosis metrics and ALS functional rating scale (adjusted R2 = 0.25, p = .033). A composite imaging biomarker comprising kurtosis and iron deposition measures yielded a maximal diagnostic accuracy of 83% (81% sensitivity, 85% specificity) and an area-under-the-curve of 0.86. Conclusion: Diffusion kurtosis is sensitive to early changes present in the motor region in ALS. We propose a composite imaging biomarker reflecting tissue microstructural changes in early ALS that may provide clinically valuable diagnostic information. Keywords: Amyotrophic lateral sclerosis (178), Magnetic resonance imaging (120), DWI (128), Motor cortex (311), Diffusion kurtosis imaging (additional)http://www.sciencedirect.com/science/article/pii/S2213158219303031
collection DOAJ
language English
format Article
sources DOAJ
author Thomas Welton
Jerome J. Maller
R. Marc Lebel
Ek T. Tan
Dominic B. Rowe
Stuart M. Grieve
spellingShingle Thomas Welton
Jerome J. Maller
R. Marc Lebel
Ek T. Tan
Dominic B. Rowe
Stuart M. Grieve
Diffusion kurtosis and quantitative susceptibility mapping MRI are sensitive to structural abnormalities in amyotrophic lateral sclerosis
NeuroImage: Clinical
author_facet Thomas Welton
Jerome J. Maller
R. Marc Lebel
Ek T. Tan
Dominic B. Rowe
Stuart M. Grieve
author_sort Thomas Welton
title Diffusion kurtosis and quantitative susceptibility mapping MRI are sensitive to structural abnormalities in amyotrophic lateral sclerosis
title_short Diffusion kurtosis and quantitative susceptibility mapping MRI are sensitive to structural abnormalities in amyotrophic lateral sclerosis
title_full Diffusion kurtosis and quantitative susceptibility mapping MRI are sensitive to structural abnormalities in amyotrophic lateral sclerosis
title_fullStr Diffusion kurtosis and quantitative susceptibility mapping MRI are sensitive to structural abnormalities in amyotrophic lateral sclerosis
title_full_unstemmed Diffusion kurtosis and quantitative susceptibility mapping MRI are sensitive to structural abnormalities in amyotrophic lateral sclerosis
title_sort diffusion kurtosis and quantitative susceptibility mapping mri are sensitive to structural abnormalities in amyotrophic lateral sclerosis
publisher Elsevier
series NeuroImage: Clinical
issn 2213-1582
publishDate 2019-01-01
description Objective: To construct a clinical diagnostic biomarker using state-of-the-art microstructural MRI in the motor cortex of people with amyotrophic lateral sclerosis (ALS). Methods: Clinical and MRI data were obtained from 21 ALS patients (aged 54 ± 14 years, 33% female) and 63 age- and gender-matched controls (aged 48 ± 18 years, 43% female). MRI was acquired at 3T and included T1-weighted scan (for volumetrics), arterial spin labelling (for cerebral blood flow), susceptibility-weighted angiography (for iron deposition) and multiband diffusion kurtosis imaging (for tissue microstructure). Group differences in imaging measures in the motor cortex were tested by general linear model and relationships to clinical variables by linear regression. Results: The ALS group had mild-to-moderate impairment (disease duration: 1.8 ± 0.8 years; ALS functional rating scale 40.2 ± 6.0; forced vital capacity 83% ± 22%). No age or gender differences were present between groups. We found significant group differences in diffusion kurtosis metrics (apparent, mean, radial and axial kurtosis: p < .01) and iron deposition in the motor cortex (p = .03). Within the ALS group, we found significant relationships between motor cortex volume, apparent diffusion and disease duration (adjusted R2 = 0.27, p = .011); and between the apparent and radial kurtosis metrics and ALS functional rating scale (adjusted R2 = 0.25, p = .033). A composite imaging biomarker comprising kurtosis and iron deposition measures yielded a maximal diagnostic accuracy of 83% (81% sensitivity, 85% specificity) and an area-under-the-curve of 0.86. Conclusion: Diffusion kurtosis is sensitive to early changes present in the motor region in ALS. We propose a composite imaging biomarker reflecting tissue microstructural changes in early ALS that may provide clinically valuable diagnostic information. Keywords: Amyotrophic lateral sclerosis (178), Magnetic resonance imaging (120), DWI (128), Motor cortex (311), Diffusion kurtosis imaging (additional)
url http://www.sciencedirect.com/science/article/pii/S2213158219303031
work_keys_str_mv AT thomaswelton diffusionkurtosisandquantitativesusceptibilitymappingmriaresensitivetostructuralabnormalitiesinamyotrophiclateralsclerosis
AT jeromejmaller diffusionkurtosisandquantitativesusceptibilitymappingmriaresensitivetostructuralabnormalitiesinamyotrophiclateralsclerosis
AT rmarclebel diffusionkurtosisandquantitativesusceptibilitymappingmriaresensitivetostructuralabnormalitiesinamyotrophiclateralsclerosis
AT ekttan diffusionkurtosisandquantitativesusceptibilitymappingmriaresensitivetostructuralabnormalitiesinamyotrophiclateralsclerosis
AT dominicbrowe diffusionkurtosisandquantitativesusceptibilitymappingmriaresensitivetostructuralabnormalitiesinamyotrophiclateralsclerosis
AT stuartmgrieve diffusionkurtosisandquantitativesusceptibilitymappingmriaresensitivetostructuralabnormalitiesinamyotrophiclateralsclerosis
_version_ 1724994322152030208